Stewart Appelrouth is Director of AIM ImmunoTech Inc.. Currently has a direct ownership of 239,765 shares of AIM, which is worth approximately $55,145. The most recent transaction as insider was on Mar 15, 2024, when has been sold 90,910 shares (Common Stock) at a price of $0.33 per share, resulting in proceeds of $30,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 240K
0% 3M change
61.07% 12M change
Total Value Held $55,145

STEWART APPELROUTH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
BUY
Open market or private purchase
$30,000 $0.33 p/Share
90,910 Added 27.49%
239,765 Common Stock
Mar 10 2023
SELL
Other acquisition or disposition
$83,895 $1.23 p/Share
68,208 Reduced 31.42%
148,855 Common Stock
Jan 03 2023
BUY
Open market or private purchase
$25,000 $0.31 p/Share
80,646 Added 27.09%
217,063 Common Stock
Apr 25 2022
BUY
Grant, award, or other acquisition
$26,215 $1.07 p/Share
24,500 Added 15.23%
136,417 Common Stock
Nov 24 2021
BUY
Grant, award, or other acquisition
$24,999 $1.29 p/Share
19,379 Added 14.76%
111,917 Common Stock
Feb 25 2021
BUY
Open market or private purchase
$24,999 $2.35 p/Share
10,638 Added 10.31%
92,538 Common Stock
SA

Stewart Appelrouth

Director
Ocala, FL

Track Institutional and Insider Activities on AIM

Follow AIM ImmunoTech Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIM shares.

Notify only if

Insider Trading

Get notified when an Aim Immuno Tech Inc. insider buys or sells AIM shares.

Notify only if

News

Receive news related to AIM ImmunoTech Inc.

Track Activities on AIM